Ipratropium
Active ingredient
- Drug class
- -
- Availability
- Prescription only
- Routes
- Respiratory (Inhalation), Nasal
- Markets covered
- 2
- Products on record
- 4
Overview
Plain-language summary, compiled from the cited regulatory records
Ipratropium is a medication used as a bronchodilator [1]. It is an anticholinergic agent [1].
Ipratropium is approved for the maintenance treatment of bronchospasm associated with chronic obstructive pulmonary disease (COPD) [1]. This includes conditions such as chronic bronchitis and emphysema [1].
This medication is available under various brand names [1].
This is not medical advice. Consult a qualified healthcare professional.
Regulatory status by market
| Market | Regulator | Products | Last revision |
|---|---|---|---|
| US United States | FDA | 3 | April 16, 2026 |
| GB United Kingdom | MHRA | 1 | September 1, 2025 |
USUnited States· FDA
3 products
Uses
1 INDICATIONS AND USAGE Ipratropium bromide HFA inhalation aerosol is indicated as a bronchodilator for maintenance treatment of bronchospasm associated with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and emphysema.
Ipratropium bromide HFA inhalation aerosol is an anticholinergic indicated for the maintenance treatment of bronchospasm associated with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and emphysema
How to take
GBUnited Kingdom· MHRA
1 product
1 product on record with this regulator. Detailed label text (uses, dosage, side effects) is being ingested — the original document is linked under Sources [2].
Drug interactions
Known interactions involving Ipratropium. Select one for details. This list is informational and not a complete interaction checker.
Interaction data compiled from DDInter (academic, CC-BY). Severity classification only - this is not a complete interaction checker and not medical advice.
Sources & citations
- [1]FDA DailyMed · 133cc2ed-f018-42… · revised April 16, 2026 [PDF]
- [2]MHRA (UK) · PL150110039 · revised September 1, 2025
Information on this page is compiled from public regulatory records. Drugvu is not affiliated with any regulator or pharmaceutical manufacturer. This is not medical advice. Always consult a qualified healthcare professional.